OptimizeRx (OPRX) Other Non-Current Liabilities (2010 - 2020)

OptimizeRx has disclosed Other Non-Current Liabilities across 11 years of filings, most recently posting $2.7 million for Q1 2020.

• In Q1 2020, Other Non-Current Liabilities rose 91.41% year-over-year to $2.7 million; the TTM figure through Mar 2020 stood at $2.7 million (up 91.41% YoY), while the FY2019 annual figure was $5.2 million, up 120.72% from the prior year.
• Other Non-Current Liabilities came in at $2.7 million for Q1 2020 at OptimizeRx, down from $5.2 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $5.2 million in Q4 2019 to a low of $1.3 million in Q4 2017.
• Average Other Non-Current Liabilities over 5 years is $2.3 million, with a median of $2.3 million recorded in 2016.
• Year-over-year, Other Non-Current Liabilities slumped 43.93% in 2017 and soared 120.72% in 2019.
• Over 5 years, Other Non-Current Liabilities stood at $2.3 million in 2016, then tumbled by 43.93% to $1.3 million in 2017, then soared by 83.84% to $2.4 million in 2018, then jumped by 120.72% to $5.2 million in 2019, then slumped by 47.89% to $2.7 million in 2020.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $2.7 million in Q1 2020, $5.2 million in Q4 2019, and $3.7 million in Q3 2019.